Medical Malpractice Insurance News

We remain cognizant of the impact that COVID-19 has had on our insureds, their staff and their loved ones. We recognize the rising Delta variant and its impact upon communities with a high unvaccinated population and continue to battle vaccine hesitancy and misinformation.

A troubling percentage of long-COVID patients are using opioids to address the scope of symptoms that can cripple one’s health for months after a diagnosis.

Experts say temperature screenings taken with non-contact infrared thermometers may be largely ineffective for curbing the spread of COVID-19 because the instrument is influenced by numerous variables.

As we emerge from the COVID-19 pandemic, it’s vital that dental practices follow appropriate guidelines to keep staff and patients safe, while protecting the practice from legal risks. Here are five ways to start.

A growing number of patients infected with COVID-19 are experiencing lasting and serious health conditions caused by the virus.

CDC says understanding the prevalence of and factors associated with COVID-19 infection among frontline providers is essential for developing effective strategies that minimize the spread of the virus in healthcare settings.

To boost childhood vaccinations rates, the U.S. Department of Health and Human Services announced that pharmacists are now permitted to administer vaccines to children ages 3 and older.

Research conducted by The Centers for Disease Control and Prevention suggests COVID-19 can result in prolonged illness, even among young adults with no underlying chronic medical conditions and those who experience mild symptoms.

Revised recommendations issued by The Centers for Disease Control say those who test positive for SARS-CoV-2 should isolate for at least 10 days after symptoms first appear.

In an effort to mitigate the dual impact of COVID-19 and the seasonal flu, vaccine manufacturers are increasing influenza vaccine production by 10 percent this year.